Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment
Open Access
- 5 June 2013
- journal article
- review article
- Published by Editorial Office of Chinese Journal of Cancer in Chinese Journal of Cancer
- Vol. 32 (6), 312-324
- https://doi.org/10.5732/cjc.012.10295
Abstract
Pancreatic neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the pancreas, are among the most common neuroendocrine tumors. The genetic causes of familial and sporadic PNETs are somewhat understood, but their molecular pathogenesis remains unknown. Most PNETs are indolent but have malignant potential. The biological behavior of an individual PNET is unpredictable; higher tumor grade, lymph node and liver metastasis, and larger tumor size generally indicate a less favorable prognosis. Endocrine testing, imaging, and histological evidence are necessary to accurately diagnose PNETs. A 4-pronged aggressive treatment approach consisting of surgery, locoregional therapy, systemic therapy, and complication control has become popular in academic centers around the world. The optimal application of the multiple systemic therapeutic modalities is under development; efficacy, safety, availability, and cost should be considered when treating a specific patient. The clinical presentation, diagnosis, and treatment of specific types of PNETs and familial PNET syndromes, including the novel Mahvash disease, are summarized.Keywords
This publication has 100 references indexed in Scilit:
- Endocrine Precursor Lesions and Microadenomas of the Duodenum and Pancreas with and without MEN1: Criteria, Molecular Concepts and Clinical SignificancePathobiology, 2007
- Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1Gut, 2007
- Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesionsGut, 2007
- Surgery Increases Survival in Patients With GastrinomaAnnals of Surgery, 2006
- Interferon-α and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?Annals of Oncology, 2006
- Malignant insulinomaCancer, 2005
- Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients: Histopathological and Molecular Genetic AnalysisThe American Journal of Pathology, 1998
- The Glucagonoma Syndrome Clinical and Pathologic Features in 21 PatientsMedicine, 1996
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995The New England Journal of Medicine, 1986
- Acromegaly Due to Secretion of Growth Hormone by an Ectopic Pancreatic Islet-Cell TumorThe New England Journal of Medicine, 1985